Overview

Levocarnitine for Dry Eye in Sjogren's Syndrome

Status:
Not yet recruiting

Trial end date:
2023-09-01

Target enrollment:

Participant gender:

Summary

This study evaluates the effectiveness of levocarnitine in the treatment of dry eye in adults with Sjogren's syndrome. This will be a crossover study design with all participants receiving both levocarnitine and placebo.

Phase:

Phase 2

Details

Lead Sponsor:

Vanderbilt University Medical Center